- Medicine Name: Vizimpro
- Generic Name: Dacomitinib
- Dosage Form & Strength: Tablets: 15mg, 30mg, 45mg
- Manufactured By: Pfizer Inc
Vizimpro is a kinase inhibitor used for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 19 deletion or exon 21 L858R substitution mutations.
Recommended Dosage: The recommended dosage of vizimpro tablets is 45 mg taken orally once daily, until the disease is progressive or unacceptable toxicity occurs. It can be taken with or without meals.
Take dosage at the same time every day. In case a dose of Vizimpro is vomited or missed, do not take an additional dose or make up a vomited/missed dose but continue with the very next scheduled dose.
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.